Cited by 714Liver Disease Diagnosis and TreatmentLiver physiology and pathologyDiet, Metabolism, and Disease

Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research

Open access
Anstee, Quentin M., Goldin, Robert D.·2006·International Journal of Experimental Pathology

Abstract

Summary: Non‐alcoholic fatty liver disease (NAFLD) represents a histological spectrum of liver disease associated with obesity, diabetes and insulin resistance that extends from isolated steatosis to steatohepatitis and cirrhosis. As well as being a potential cause of progressive liver disease in its own right, steatosis has been shown to be an important cofactor in the pathogenesis of many other liver diseases. Animal models of NAFLD may be divided into two broad categories: those caused by genetic mutation and those with an acquired phenotype produced by dietary or pharmacological manipulation. The literature contains numerous different mouse models that exhibit histological evidence of hepatic steatosis or, more variably, steatohepatitis; however, few replicate the entire human phenotype. The genetic leptin‐deficient (ob/ob) or leptin‐resistant (db/db) mouse and the dietary methionine/choline‐deficient model are used in the majority of published research. More recently, targeted gene disruption and the use of supra‐nutritional diets to induce NAFLD have gained greater prominence as researchers have attempted to bridge the phenotype gap between the available models and the human disease. Using the physiological processes that underlie the pathogenesis and progression of NAFLD as a framework, we review the literature describing currently available mouse models of NAFLD, highlight the strengths and weaknesses of established models and describe the key findings that have furthered the understanding of disease pathogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.0959-9673.2006.00465.x

Cites

129 of 129 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Dragani T.A. (ed.) (1998) Human Polygenic Diseases: Animal Models. Australia: Harwood.

Cited by

Sorted by citations

Authors
Anstee, Q. M., & Goldin, R. D.
Affiliations
Imperial College London (GB)
Corresponding author
Goldin, Robert D.
Venue
International Journal of Experimental Pathology
Publisher
Wiley
Published
2006-01-23
Volume
87
Issue
1
Pages
1-16
ISSN
  • 0959-9673 (ISSN-L)
  • 1365-2613
OpenAlex
W1523155649
Cited by
714
References
129
Citations by year
2026: 11 · 2025: 16 · 2024: 23 · 2023: 35 · 2022: 29 · 2021: 34 · 2020: 44 · 2019: 36 · 2018: 44 · 2017: 46 · 2016: 55 · 2015: 48 · 2014: 53 · 2013: 53 · 2012: 43
FWCI
2.78
Type
journal article
Language
en
Open access
Locations
  • International Journal of Experimental Pathology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
Keywords
non-alcoholic fatty liver disease, steatohepatitis, mouse model, hepatic steatosis, leptin-deficient ob/ob mice, methionine-choline-deficient diet, targeted gene disruption, obesity, insulin resistance, NAFLD pathogenesis
MeSH terms
Adipose Tissue, Animals, Fatty Acids, Fatty Liver, Mice, Mutant Strains, Triglycerides, Leptin, Models, Animal, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review